New York State Teachers Retirement System Cuts Holdings in HCA Healthcare, Inc. $HCA

New York State Teachers Retirement System lowered its position in shares of HCA Healthcare, Inc. (NYSE:HCAFree Report) by 8.8% during the 3rd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 156,660 shares of the company’s stock after selling 15,122 shares during the quarter. New York State Teachers Retirement System owned 0.07% of HCA Healthcare worth $66,768,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds and other institutional investors have also bought and sold shares of the company. Brighton Jones LLC purchased a new stake in shares of HCA Healthcare during the 4th quarter valued at $1,021,000. NewEdge Advisors LLC raised its position in HCA Healthcare by 11.9% in the first quarter. NewEdge Advisors LLC now owns 3,859 shares of the company’s stock worth $1,334,000 after acquiring an additional 409 shares during the period. Focus Partners Wealth grew its position in shares of HCA Healthcare by 4.8% during the 1st quarter. Focus Partners Wealth now owns 6,617 shares of the company’s stock valued at $2,287,000 after acquiring an additional 301 shares during the period. Kera Capital Partners Inc. purchased a new position in HCA Healthcare in the second quarter valued at approximately $221,000. Finally, RB Capital Management LLC increased its position in HCA Healthcare by 6.9% in the second quarter. RB Capital Management LLC now owns 3,220 shares of the company’s stock worth $1,233,000 after buying an additional 208 shares during the last quarter. Hedge funds and other institutional investors own 62.73% of the company’s stock.

Insider Buying and Selling

In related news, EVP Michael R. Mcalevey sold 3,892 shares of the stock in a transaction on Wednesday, November 5th. The stock was sold at an average price of $473.79, for a total value of $1,843,990.68. Following the transaction, the executive vice president owned 3,487 shares of the company’s stock, valued at $1,652,105.73. This represents a 52.74% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. 1.30% of the stock is currently owned by corporate insiders.

HCA Healthcare Stock Performance

Shares of HCA stock opened at $472.40 on Monday. HCA Healthcare, Inc. has a 52-week low of $295.00 and a 52-week high of $520.00. The business’s fifty day moving average is $479.87 and its 200 day moving average is $427.76. The company has a market capitalization of $107.80 billion, a PE ratio of 18.26, a price-to-earnings-growth ratio of 1.30 and a beta of 1.36.

HCA Healthcare (NYSE:HCAGet Free Report) last released its quarterly earnings results on Friday, October 24th. The company reported $6.96 earnings per share for the quarter, beating the consensus estimate of $5.64 by $1.32. The firm had revenue of $19.16 billion for the quarter, compared to analysts’ expectations of $18.55 billion. HCA Healthcare had a negative return on equity of 792.25% and a net margin of 8.53%.The company’s revenue was up 9.6% compared to the same quarter last year. During the same quarter last year, the firm posted $4.90 EPS. HCA Healthcare has set its FY 2025 guidance at 27.000-28.000 EPS. On average, sell-side analysts forecast that HCA Healthcare, Inc. will post 24.98 EPS for the current fiscal year.

HCA Healthcare Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Monday, December 29th. Stockholders of record on Monday, December 15th were given a dividend of $0.72 per share. The ex-dividend date was Monday, December 15th. This represents a $2.88 annualized dividend and a dividend yield of 0.6%. HCA Healthcare’s dividend payout ratio (DPR) is 11.13%.

HCA Healthcare News Summary

Here are the key news stories impacting HCA Healthcare this week:

Wall Street Analysts Forecast Growth

Several equities research analysts recently weighed in on the company. Oppenheimer lifted their price objective on HCA Healthcare from $400.00 to $500.00 and gave the stock an “outperform” rating in a report on Monday, October 27th. Truist Financial lifted their target price on shares of HCA Healthcare from $495.00 to $520.00 and gave the stock a “buy” rating in a research note on Monday, January 5th. Bank of America raised their price objective on shares of HCA Healthcare from $430.00 to $470.00 and gave the stock a “neutral” rating in a report on Monday, October 27th. Sanford C. Bernstein restated a “market perform” rating and set a $503.00 target price on shares of HCA Healthcare in a research report on Tuesday, January 6th. Finally, Royal Bank Of Canada boosted their price objective on HCA Healthcare from $482.00 to $525.00 and gave the company an “outperform” rating in a research note on Friday, December 19th. Fourteen analysts have rated the stock with a Buy rating, nine have issued a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat, HCA Healthcare currently has a consensus rating of “Moderate Buy” and an average price target of $485.95.

View Our Latest Report on HCA

HCA Healthcare Company Profile

(Free Report)

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.

Further Reading

Institutional Ownership by Quarter for HCA Healthcare (NYSE:HCA)

Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.